Trials / Completed
CompletedNCT04627636
MTPr With Shockwave on Pain & Function of SHS in Stroke
Myofascial Trigger Points Release With Shockwave Therapy on Pain and Function of Shoulder Hand Syndrome in Stroke Patients With Diabetic Neuropathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- October 6 University · Academic / Other
- Sex
- All
- Age
- 45 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Background: shoulder-hand syndrome is considered a significant reason for the reduction of upper limb functions after stroke. Purpose: To investigate the influence of Myofascial Trigger Points (MTrPs) release and shockwave therapy on pain and functions of the upper extremity in stroke patients with diabetic neuropathy.
Detailed description
Methods: two equal groups of thirty stroke patients, divided into, study group: which treated with MTrPs release combined with shockwave therapy and conventional program, while control group: treated with a conventional selected exercise program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Myofascial trigger points pressure (MTrP) release | Myofascial trigger points pressure (MTrP) release technique, the initial step was to recognize and find the trigger points (TP) , and The second step after TP palpation was the MTrP release technique, as follow, by one or both hands, the thumbs or four fingers of the therapist applied a maintained pressure, pushing internal toward the middle |
| OTHER | Shockwave therapy application | The JEST-2000 (JOEUN Medical, Dae-Jeon, South Korea) was used for the ESWT. The application of pressure pulses of ESWT was centered around the flexor muscles with hypertonia |
| OTHER | conventional therapy | Passive ROM exercises performed by the therapist and Bobath Neurodevelopmental Approach (prolonged stretch): The Intervention methods for Bobath involved the activation of key points of control for the reduction of tone |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2019-12-30
- Completion
- 2020-01-30
- First posted
- 2020-11-13
- Last updated
- 2020-11-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04627636. Inclusion in this directory is not an endorsement.